Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06312514

Lafiya HIV-status Neutral Study - Protocol

Status-neutral Community-based Multilevel Intervention to Address Intersectional Stigma and Discrimination, and Increase HIV Testing, PrEP, and ART Uptake Among YGBMSM in Ghanaian Slums: A Clustered Randomized Control Trial Protocol

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
880 (estimated)
Sponsor
University of Rochester · Academic / Other
Sex
Male
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to adapt and evaluate the feasibility of "Lafiya," which means "Wellness" in Hausa, a multilevel intersectional stigma \& discrimination (ISD) and HIV testing intervention, to a status-neutral intervention to increase HIV testing, PrEP, and ART Uptake (HPART) among young gay, bisexual, and other men who have sex with men in Ghanaian slums. Specific objectives include, Assessing intersectional stigma and options for HPART implementation, Adapting Lafiya to a status-neutral intervention to address intersectional stigma and increase HPART uptake among YGBMSM, Test acceptance, feasibility, appropriateness, and preliminary efficacy of Lafiya to address intersectional stigma and increase HIVST uptake.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLAFIYAThe Lafiya intervention is a comprehensive program designed to address the intersectional stigma and discrimination challenges faced by marginalized communities, particularly among Gay, Bisexual, and other Men who have Sex with Men (GBMSM). It aims to enhance HIV prevention, care, and treatment outcomes, with a focus on increasing HIV self-testing (HIVST) uptake among these key populations in Ghanaian urban slum settings.

Timeline

Start date
2025-04-20
Primary completion
2028-08-29
Completion
2028-08-29
First posted
2024-03-15
Last updated
2025-02-06

Locations

1 site across 1 country: Ghana

Source: ClinicalTrials.gov record NCT06312514. Inclusion in this directory is not an endorsement.